What are you looking for?

We developed the INTERVALS™ online platform to share and explore RRP* assessment data and results, along with mechanistic studies on smoking-related diseases.

 

With INTERVALS™, you can browse, share and analyze

pre-clinical and clinical

data, study design, and methods

for RRPs – inlcuding potential and candidate Modified Risk Tobacco Products (MRTPs).

 

The entire RRP research community is welcome to join us and use the platform: INTERVALS™ is meant to be a comprehensive RRP repository with data from various sources, in addition to PMI’s research data.

Independant verification

We welcome independent verification of our results

Read about Systems Toxicology in depth

 

Two of our latest added studies describe an independent review of a multitude of PMI’s scientific publications on Platform 1. Via a web portal, reviewers in Tier 1 had access to all associated clinical and pre-clinical studies results, together with their corresponding protocols, reports, raw data, and publications. The reports issued by the Tier 1 reviewers were further reviewed by expert scientists in Tier 2. Learn more about how these studies were conducted and their findings at INTERVALS.science.

Sharing data on INTERVALS™

Explore the data

Our RRPs

Reduced-risk products ("RRPs") is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.